CTNG Testing Market Outlook from 2024 to 2034

The CTNG testing market is projected to be worth US$ 1.8 billion in 2024. The market is anticipated to reach US$ 3.9 billion by 2034. The market is further expected to surge at a CAGR of 8.0% during the forecast period 2024 to 2034.

Key Market Trends and Highlights

The expansion of healthcare infrastructure, particularly in emerging economies, creates opportunities for increased access to CTNG testing services, leading to market expansion.

  • Ongoing innovations in CT/NG screening technologies and strategic collaborations among healthcare providers, diagnostic companies, and research institutions create new opportunities for market players to develop and offer advanced testing solutions.
  • Government initiatives aimed at promoting STI awareness, prevention, and control, coupled with regulatory mandates for routine STI screening, drive the adoption of CTNG testing technologies.
  • The rise in antibiotic resistant strains of chlamydia and gonorrhea underscores the importance of accurate and timely diagnosis through CTNG testing, driving market growth.
Attributes Key Insights
CTNG Testing Market Estimated Size in 2024 US$ 1.8 billion
Projected Market Value in 2034 US$ 3.9 billion
Value-based CAGR from 2024 to 2034 8.0%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2019 to 2023 Historical Analysis vs. 2024 to 2034 Market Forecast Projections

The scope for CTNG testing rose at a 10.2% CAGR between 2019 and 2023. The global market is anticipated to grow at a moderate CAGR of 8.0% over the forecast period 2024 to 2034.

The CTNG testing Market witnessed steady growth during the historical period, driven by factors such as increasing awareness about STIs, advancements in diagnostic technologies, and expansion of healthcare infrastructure.

Significant advancements in CTNG testing technologies, including the introduction of multi parameter CT/NG NAATs and point of care testing solutions, enhanced the accuracy, sensitivity, and accessibility of diagnostic tests.

The rising incidence of chlamydia and gonorrhea infections globally, coupled with the emergence of antibiotic resistant strains, underscored the need for effective screening and detection methods, driving market demand.

The forecast period is expected to witness continued technological innovations in CTNG testing, including the development of next generation molecular assays, advanced point of care devices, and integrated diagnostic platforms, driving market expansion.

The increasing demand for point of care testing solutions for STIs, driven by the need for rapid and convenient diagnostics in diverse healthcare settings, is expected to fuel market growth during the forecast period.

The expansion of telemedicine platforms and remote testing services is anticipated to facilitate broader access to CTNG testing, particularly in underserved rural areas and resource limited settings, contributing to market expansion.

CTNG Testing Market Key Drivers

Increasing awareness about sexually transmitted infections, including chlamydia and gonorrhea, among the population drives the demand for CTNG testing.

  • Technological advancements, particularly in multi parameter CT/NG Nucleic Acid Amplification Tests, enhance the accuracy, sensitivity, and speed of CTNG testing, making it more accessible and efficient.
  • The growing prevalence of chlamydia and gonorrhea infections globally highlights the urgent need for effective screening and detection methods, fueling the demand for CTNG testing.
  • The integration of CT/NG diagnostic tests into routine STI screening programs and healthcare initiatives promotes early detection, treatment, and prevention efforts, driving the growth of the market.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Challenges in the CTNG Testing Market

The cost associated with CTNG testing procedures, including diagnostic kits, laboratory equipment, and personnel training, can be prohibitive for healthcare providers and patients, hindering widespread adoption and accessibility.

  • Inadequate access to healthcare services, particularly in rural and underserved areas, may limit the availability of CTNG testing facilities and hinder patient access to diagnostic services.
  • Stigma associated with STIs and privacy concerns may deter individuals from seeking CTNG testing, leading to underdiagnosis and underreporting of infections, thereby impeding market growth.
  • Stringent regulatory requirements for CTNG testing products, including approvals, quality assurance, and compliance with data privacy regulations, can pose barriers to market entry and product commercialization.

Country-wise Insights

The below table showcases revenues in terms of the top 5 leading countries, spearheaded by Korea and the United Kingdom. The countries are expected to lead the market through 2034.

Countries Forecast CAGRs from 2024 to 2034
The United States 8.3%
The United Kingdom 9.3%
Japan 9.0%
China 8.7%
Korea 9.8%

Increasing Prevalence of Chlamydia and Gonorrhea Driving the Market in the United States

The CTNG testing market in the United States expected to expand at a CAGR of 8.3% through 2034. The country has seen a rise in the prevalence of chlamydia and gonorrhea infections, particularly among sexually active individuals and high risk populations, driving the demand for CTNG testing services to address the public health burden of these STIs.

Stringent regulatory requirements set by organizations such as the Food and Drug Administration mandate the need for comprehensive CTNG testing as part of regulatory approvals for medical devices, diagnostics, and pharmaceutical products, fostering market growth.

National Screening Programs to Accelerate Market Growth in the United Kingdom

The CTNG testing market in the United Kingdom is anticipated to expand at a CAGR of 9.3% through 2034. The implementation of national screening programs, such as the National Chlamydia Screening Program and the National Gonorrhea Screening Programme, promotes routine CTNG testing among sexually active individuals, contributing to increased testing rates and early detection of infections.

Government funding and support for STI prevention, control, and screening initiatives, including investments in sexual health services and public health campaigns, drive the implementation of CTNG testing services and raise public awareness about the importance of STI screening and treatment.

Expansion of Healthcare Infrastructure Spearhead the Market in China

CTNG testing trends in China are taking a turn for the better. An 8.7% CAGR is forecast for the country from 2024 to 2034. The expansion of healthcare infrastructure in China, including the establishment of sexual health clinics, community health centers, and primary care facilities, facilitates access to CTNG testing services for individuals seeking sexual health care, particularly in urban and rural areas.

Increasing awareness about STIs and sexual health issues, driven by educational initiatives, media campaigns, and community outreach programs, encourages individuals to seek CTNG testing services and promotes safe sexual practices, reducing the spread of STIs.

Technological Advancements in Testing Fueling the Market in Japan

The CTNG testing market in Japan is poised to expand at a CAGR of 9.0% through 2034. Ongoing advancements in CTNG testing technologies, including nucleic acid amplification tests, molecular assays, and point of care testing devices, enhance the accuracy, sensitivity, and accessibility of testing services, driving market adoption and utilization.

Increased investments by private sector companies in STI diagnostics and healthcare services, coupled with market liberalization policies, stimulate competition, innovation, and market growth in the market.

High Prevalence of Antibiotic Resistance Driving the Demand in Korea

The CTNG testing market in Korea is anticipated to expand at a CAGR of 9.8% through 2034. The emergence of antibiotic resistant strains of chlamydia and gonorrhea in Korea highlights the importance of early detection and appropriate treatment, driving the demand for CTNG testing services to guide therapeutic decisions and prevent the spread of drug resistant infections.

Increasing emphasis on sexual health education in schools, universities, and community organizations raises awareness about STIs, promotes safe sexual practices, and encourages regular STI screening among young people and at risk populations, driving the demand for CTNG testing services.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

The below table highlights how assays and kits segment is projected to lead the market in terms of product, and is expected to account for a CAGR of 7.7% through 2034. Based on test type, the laboratory segment is expected to account for a CAGR of 7.5% through 2034.

Category CAGR from 2024 to 2034
Assays and Kits 7.7%
Laboratory 7.5%

Assays and Kits Claim High Demand for CTNG Testing

Based on product, the assays and kits segment is expected to continue dominating the CTNG testing market. Ongoing advancements in assay and kit technologies, including nucleic acid amplification tests, polymerase chain reaction, and loop mediated isothermal amplification, enhance the sensitivity, specificity, and speed of CTNG detection, driving demand for assay and kit products.

Assays and kits offer high levels of accuracy and reliability in detecting chlamydia and gonorrhea infections, making them essential tools for healthcare providers and laboratories conducting routine screening, diagnosis, and surveillance programs.

Assays and kits are designed to be user friendly, with standardized protocols and procedures that simplify sample collection, processing, and interpretation, enabling healthcare professionals to perform CTNG testing efficiently in diverse clinical and laboratory settings.

Laboratory to Hold High Demand for CTNG Testing

In terms of test type, the laboratory segment is expected to continue dominating the CTNG testing market, attributed to several key factors. Laboratory based tests offer high levels of accuracy and precision in detecting chlamydia and gonorrhea infections, making them the gold standard for diagnosis and confirmation of STIs.

Laboratories have the infrastructure, equipment, and expertise to perform comprehensive CTNG testing, including nucleic acid amplification tests, culture based methods, and antimicrobial susceptibility testing, enabling thorough assessment and characterization of STI pathogens.

Laboratories offer specialized testing services, such as genotyping, serotyping, and molecular epidemiology, to identify strain variations, antimicrobial resistance patterns, and transmission dynamics of chlamydia and gonorrhea pathogens, facilitating targeted treatment and public health interventions.

Competitive Landscape

The competitive landscape of the CTNG testing market is characterized by the presence of several established players, emerging companies, and innovative startups competing to gain market share and meet the growing demand for accurate, reliable, and accessible testing solutions for chlamydia and gonorrhea infections.

Company Portfolio

  • Abbott Laboratories is a key player in the CTNG testing market, providing a range of diagnostic tests, including nucleic acid amplification assays and rapid point of care testing solutions, for the detection of chlamydia and gonorrhea infections.
  • bioMérieux is a global leader in infectious disease diagnostics, offering a wide range of molecular assays, automated platforms, and laboratory solutions for STI testing, including chlamydia and gonorrhea detection.

Key Coverage in the CTNG Testing Industry Report

  • CTNG Testing Market Size
  • CTNG Testing Market Growth
  • CTNG Testing Market Value
  • Growth Opportunities for the CTNG testing
  • CTNG Testing Market Growth
  • Market Share for CTNG testing
  • Developments in the CTNG Testing Market
  • CTNG Detection
  • STI Diagnostic Tests
  • Genital Infection Testing
  • CTNG Testing Market Analysis
  • CT/NG Diagnostic Tests Market Outlook
  • Chlamydia and Gonorrhea Testing Trends

Report Scope

Attribute Details
Estimated Market Size in 2024 US$ 1.8 billion
Projected Market Valuation in 2034 US$ 3.9 billion
Value-based CAGR 2024 to 2034 8.0%
Forecast Period 2024 to 2034
Historical Data Available for 2019 to 2023
Market Analysis Value in US$ Billion
Key Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East & Africa
Key Market Segments Covered
  • Product
  • Test Type
  • Technology
  • Region
Key Countries Profiled
  • The United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • France
  • France
  • Spain
  • Italy
  • Russia
  • Poland
  • Czech Republic
  • Romania
  • India
  • Bangladesh
  • Australia
  • New Zealand
  • China
  • Japan
  • South Korea
  • GCC countries
  • South Africa
  • Israel
Key Companies Profiled
  • F. Hoffmann-La Roche Ltd.
  • Hologic Inc.
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Siemens Healthineers AG
  • Danaher
  • Becton, Dickinson and Company
  • bioMérieux SA

Segmentation Analysis of the CTNG Testing Market

By Product:

  • Assays and Kits
  • Instruments/Analyzers

By Test Type:

  • Laboratory
  • Point of Care Testing

By Technology:

  • INAAT
  • PCR
  • Immunodiagnostics
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East and Africa

Frequently Asked Questions

What is the anticipated value of the CTNG Testing market in 2024?

The CTNG testing market is projected to reach a valuation of US$ 1.8 Billion in 2024.

What is the expected CAGR for the CTNG Testing market until 2034?

The CTNG testing industry is set to expand by a CAGR of 8.0% through 2034.

How much valuation is projected for the CTNG Testing market in 2034?

The CTNG testing market is forecast to reach US$ 3.9 Billion by 2034.

Which country is projected to lead the CTNG Testing market?

Korea is expected to be the top performing market, exhibiting a CAGR of 9.8% through 2034.

Which is the dominant product in the CTNG Testing domain?

Assays and kits segment is preferred, and is expected to account for a CAGR of 7.7% through 2034.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

    4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2019 to 2023

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2024 to 2034

        5.3.1. Assays & kits

        5.3.2. Instruments/Analyzers

    5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023

    5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Test Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2019 to 2023

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2024 to 2034

        6.3.1. Laboratory

        6.3.2. Point-of-care testing

    6.4. Y-o-Y Growth Trend Analysis By Test Type, 2019 to 2023

    6.5. Absolute $ Opportunity Analysis By Test Type, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Technology

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2019 to 2023

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2024 to 2034

        7.3.1. INAAT

        7.3.2. PCR

        7.3.3. Immunodiagnostics

        7.3.4. Others

    7.4. Y-o-Y Growth Trend Analysis By Technology, 2019 to 2023

    7.5. Absolute $ Opportunity Analysis By Technology, 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Product

        9.2.3. By Test Type

        9.2.4. By Technology

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By Test Type

        9.3.4. By Technology

    9.4. Key Takeaways

10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product

        10.2.3. By Test Type

        10.2.4. By Technology

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Test Type

        10.3.4. By Technology

    10.4. Key Takeaways

11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. UK

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Product

        11.2.3. By Test Type

        11.2.4. By Technology

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Test Type

        11.3.4. By Technology

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Product

        12.2.3. By Test Type

        12.2.4. By Technology

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Test Type

        12.3.4. By Technology

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Product

        13.2.3. By Test Type

        13.2.4. By Technology

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Test Type

        13.3.4. By Technology

    13.4. Key Takeaways

14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Product

        14.2.3. By Test Type

        14.2.4. By Technology

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By Test Type

        14.3.4. By Technology

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Product

        15.2.3. By Test Type

        15.2.4. By Technology

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product

        15.3.3. By Test Type

        15.3.4. By Technology

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2023

            16.1.2.1. By Product

            16.1.2.2. By Test Type

            16.1.2.3. By Technology

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2023

            16.2.2.1. By Product

            16.2.2.2. By Test Type

            16.2.2.3. By Technology

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2023

            16.3.2.1. By Product

            16.3.2.2. By Test Type

            16.3.2.3. By Technology

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2023

            16.4.2.1. By Product

            16.4.2.2. By Test Type

            16.4.2.3. By Technology

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2023

            16.5.2.1. By Product

            16.5.2.2. By Test Type

            16.5.2.3. By Technology

    16.6. UK

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2023

            16.6.2.1. By Product

            16.6.2.2. By Test Type

            16.6.2.3. By Technology

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2023

            16.7.2.1. By Product

            16.7.2.2. By Test Type

            16.7.2.3. By Technology

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2023

            16.8.2.1. By Product

            16.8.2.2. By Test Type

            16.8.2.3. By Technology

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2023

            16.9.2.1. By Product

            16.9.2.2. By Test Type

            16.9.2.3. By Technology

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2023

            16.10.2.1. By Product

            16.10.2.2. By Test Type

            16.10.2.3. By Technology

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2023

            16.11.2.1. By Product

            16.11.2.2. By Test Type

            16.11.2.3. By Technology

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2023

            16.12.2.1. By Product

            16.12.2.2. By Test Type

            16.12.2.3. By Technology

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2023

            16.13.2.1. By Product

            16.13.2.2. By Test Type

            16.13.2.3. By Technology

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2023

            16.14.2.1. By Product

            16.14.2.2. By Test Type

            16.14.2.3. By Technology

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2023

            16.15.2.1. By Product

            16.15.2.2. By Test Type

            16.15.2.3. By Technology

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2023

            16.16.2.1. By Product

            16.16.2.2. By Test Type

            16.16.2.3. By Technology

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2023

            16.17.2.1. By Product

            16.17.2.2. By Test Type

            16.17.2.3. By Technology

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2023

            16.18.2.1. By Product

            16.18.2.2. By Test Type

            16.18.2.3. By Technology

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2023

            16.19.2.1. By Product

            16.19.2.2. By Test Type

            16.19.2.3. By Technology

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2023

            16.20.2.1. By Product

            16.20.2.2. By Test Type

            16.20.2.3. By Technology

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2023

            16.21.2.1. By Product

            16.21.2.2. By Test Type

            16.21.2.3. By Technology

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2023

            16.22.2.1. By Product

            16.22.2.2. By Test Type

            16.22.2.3. By Technology

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2023

            16.23.2.1. By Product

            16.23.2.2. By Test Type

            16.23.2.3. By Technology

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product

        17.3.3. By Test Type

        17.3.4. By Technology

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. F. Hoffmann-La Roche Ltd. (Switzerland)

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Hologic, Inc. (USA)

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Thermo Fisher Scientific Inc. (USA)

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Abbott Laboratories (USA)

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Bio-Rad Laboratories, Inc. (USA)

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Siemens Healthineers AG (Germany)

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Danaher (USA)

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Becton

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Dickinson and Company (USA)

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Bacterial Diagnostics in Aquaculture Market

August 2023

REP-GB-9923

250 pages

Healthcare

Drug of Abuse Testing Market

June 2023

REP-GB-1649

306 pages

Healthcare

Preclinical Medical Device Testing Services Market

November 2022

REP-GB-14994

300 pages

Healthcare

Cystatin C Testing Market

September 2022

REP-GB-10541

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

CTNG Testing Market

Schedule a Call